Website stats and analysis

The DNA Damage Response (DDR) Network DNA Damage Response (DDR) network is a system of cellular pathways that monitor, signal and repair DNA damage. In cancer cells, replication stress induced by oncogenes (e.g., MYC or RAS), genetic mutations in DNA repair machinery (e.g., BRCA or FANCA), genetic mutations leading to a dysregulated cell cycle (e.g., TP or ATM) or other genetic alte...

2.48 Rating by Usitestat

sierraoncology.com was registered 8 years 3 weeks ago. It has a alexa rank of #1,862,972 in the world. It is a domain having .com extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, sierraoncology.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 471
Daily Pageviews: 942

Estimated Valuation

Income Per Day: $ 3.00
Estimated Worth: $ 720.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 1,862,972
PageSpeed Score: 76 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

104.196.36.229

Hosted Country:

United States US

Location Latitude:

32.8886

Location Longitude:

-80.0075

Traffic Classification

Total Traffic: No Data
Direct Traffic: 49.56%
Referral Traffic: 9.66%
Search Traffic: 33.60%
Social Traffic: 7.17%
Mail Traffic: 0%
Display Traffic: 0%

Search Engine Results For sierraoncology.com

Sierra Oncology | Targeted Cancer Treatments | Home

- https://www.sierraoncology.com/

Sierra Oncology is an ambitious clinical stage drug development company, advancing targeted therapies for treating cancer patients.


Momelotinib Overview - Sierra Oncology

- https://www.sierraoncology.com/momelotinib-overview/

Momelotinib is a potent, selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis (MF).


Sierra Oncology | Investor Relations - Investor Relations

- http://investor.sierraoncology.com/

Oct 02, 2020 · Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the registration and commercialization of momelotinib, a JAK1, JAK2 & ACVR1...


Sierra Oncology Appoints Dr. Stephen Dilly as President ...

- http://investor.sierraoncology.com/2020-05-26-Sierra-Oncology-Appoints-Dr-Stephen-Dilly-as-President-and-Chief-Executive-Officer

May 26, 2020 · About Sierra Oncology Sierra Oncology is a late stage drug development company focused on achieving the successful registration and commercialization of...


Sierra Oncology, Inc. (SRRA) Company Profile & Facts ...

- https://finance.yahoo.com/quote/SRRA/profile/

Sierra Oncology, Inc. researches, develops, and commercializes therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib,...


Sierra Oncology - Crunchbase Company Profile & Funding

- https://www.crunchbase.com/organization/pronai-therapeutics

Sierra Oncology is a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology-focused...


Sierra Oncology, Inc. (SRRA) Stock Price, News, Quote ...

- https://finance.yahoo.com/quote/SRRA/

Find the latest Sierra Oncology, Inc. (SRRA) stock quote, history, news and other vital information to help you with your stock trading and investing.


SIERRA HEMATOLOGY & ONCOLOGY

- http://www.sierrahemonc.com/

Sierra Hematology & Oncology is dedicated to care of patients with hematology and oncology disorders. We strive to provide excellent, courteous and timely service.


Sierra Oncology Reports Third Quarter 2020 Results

- https://www.prnewswire.com/news-releases/sierra-oncology-reports-third-quarter-2020-results-301166576.html

17 hours ago · - MOMENTUM Phase 3 clinical trial enrollment on track; top-line data anticipated in H1 2022 - VANCOUVER, BC, Nov. 5, 2020 /PRNewswire/ - Sierra Oncology, Inc....


Sierra Oncology, Inc: 3Q Earnings Snapshot | Business ...

- https://journalstar.com/business/sierra-oncology-inc-3q-earnings-snapshot/article_40038973-0b61-51a5-9b6d-7134c8fa430e.html

15 hours ago · VANCOUVER, British Columbia (AP) — Sierra Oncology, Inc (SRRA) on Thursday reported a loss of $14.5 million in its third quarter. On a per …


Sierra Oncology Company Profile: Stock Performance ...

- https://pitchbook.com/profiles/company/54185-32

Sierra Oncology General Information Description. Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization...


Sierra Oncology | Hopen Life Science Ventures

- https://hopenls.com/sierra-oncology

Sierra Oncology is a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology-focused...


Sierra Oncology | VentureRadar

- https://www.ventureradar.com/organisation/Sierra Oncology/1b78d29c-f101-4730-baa7-a4a71b253644

Website: https://sierraoncology.com. Sierra Oncology is a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with unmet...


SRRA:NASDAQ GM Stock Quote - Sierra Oncology Inc ...

- https://www.bloomberg.com/quote/SRRA:US

Sierra Oncology is a late stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in...


DNAI Stock Quote - Sierra Oncology Inc - Bloomberg Markets

- https://www.bloomberg.com/quote/DNAI:US

Sierra Oncology is a late stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in...


Mark Kowalski - Chief Medical Off.. - Sierra Oncology ...

- https://www.zoominfo.com/p/Mark-Kowalski/690706807

Sierra Oncology is a clinical stage drug development company. The company researches, develops, and commercializes DNA Damage Response (DDR) therapeutics for the treatment of...


Sierra Oncology Inc SRRA - Quotes, Financials, News ...

- https://money.usnews.com/investing/stocks/srra-sierra-oncology-inc

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the...


Sierra Oncology Inc. (SRRA:US) | Company Profile | TMX Money

- https://money.tmx.com/en/quote/SRRA:US/company

Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response (DDR) therapeutics for...


Sierra Oncology - Abingworth LLP

- https://www.abingworth.com/portfolio/sierra-oncology

Sierra Oncology is a late-stage drug development company based in Vancouver focused on the development and commercialization of Momelotinib, a JAK1, JAK2 & ACVR1 inhibitor with...


Sierra Oncology Reports Third Quarter 2020 Results ...

- https://markets.businessinsider.com/news/stocks/sierra-oncology-reports-third-quarter-2020-results-1029769852

1 day ago · Sierra Oncology excludes a non-cash charge pertaining to the changes in fair value of an obligation to issue common stock and a warrant to Gilead because it is a...

Page Resources Breakdown

Homepage Links Analysis

Sierra Oncology | Targeted Cancer Treatments | Home
Sierra Oncology is an ambitious clinical stage drug development company, advancing targeted therapies for treating cancer patients.

Website Inpage Analysis

H1 Headings: 2 H2 Headings: 1
H3 Headings: 3 H4 Headings: 2
H5 Headings: 4 H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 3
Google Adsense: Not Applicable Google Analytics: UA-89807499-1

Websites Hosted on Same IP (i.e. 104.196.36.229)

Career Ready & Elective Courses | eDynamic Learning

- edynamiclearning.com

Our program is the only one that offers students sequenced learning tracks aligned to national standards, bringing students to the doorstep of industry-endorsed certification!

  610,546   $ 2,160.00

Pima JTED Career and Technical Education District

- pimajted.org

JTED, Joint Technical Education District, Technology Education, Pima County, Pima Community College, Career and Technical Education Classes, Vocational Education for the 21st...

  783,789   $ 1,680.00

ERDCO Engineering Corporation | flow meters, switches, transmitters

- erdco.com

Est. in 1946, ERDCO supplies industries with flow meters for the measurement of utility liquids, gases and steam—such as water, air, nitrogen, lubricants.

  2,971,401   $ 480.00

Kapost | Content Operations and Marketing Platform

- kapost.com

Kapost provides content operations software and services to unite revenue teams and align the customer journey. Learn about our content marketing platform.

  108,314   $ 115,200.00

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Server: nginx
Date: Thu, 11 Jul 2019 07:30:19 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Keep-Alive: timeout=20
Vary: Accept-Encoding,Cookie
Link: ; rel="https://api.w.org/"
WPE-Backend: apache
X-Cacheable: SHORT
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 8
X-Pass-Why:
X-Cache-Group: normal
X-Type: default
Content-Encoding: gzip

Domain Information

Domain Registrar: Network Solutions, LLC
Registration Date: 2016-10-27 8 years 3 weeks 1 day ago
Last Modified: 2018-08-27 6 years 2 months 3 weeks ago

Domain Nameserver Information

Host IP Address Country
ns49.worldnic.com 162.159.26.111 United States United States
ns50.worldnic.com 162.159.27.50 United States United States

DNS Record Analysis

Host Type TTL Extra
sierraoncology.com A 7092 IP: 104.196.36.229
sierraoncology.com NS 7200 Target: ns50.worldnic.com
sierraoncology.com NS 7200 Target: ns49.worldnic.com
sierraoncology.com SOA 7200 MNAME: NS49.WORLDNIC.com
RNAME: namehost.WORLDNIC.com
Serial: 119043010
Refresh: 10800
Retry: 3600
Expire: 604800
sierraoncology.com MX 7200 Target: sierraoncology-com.mail.protection.outlook.com
sierraoncology.com TXT 3600 TXT:
adobe-idp-site-verification=f11b2beb73f9
15faf8942e0cb3fa4333b94217a884ff83b1a89e
95b9ae4e3e9e
sierraoncology.com TXT 7200 TXT:
ciscocidomainverification=6ba1127942eab4
02c9954b2ef8409fe6e7edb8f05a1daaa226c6df
65c8ff4234
sierraoncology.com TXT 7200 TXT: v=spf1
include:spf.protection.outlook.com -all
sierraoncology.com TXT 3600 TXT: MS=ms76950703

Top Organic Keyword

1. sierra oncology
2. srra sto
3. pronai therapeutics inc
4. cdc7 pdl1 combination
5. sierra oncology inc.

Top Paid Keyword

Not Applicable

Full WHOIS Lookup

Domain Name: SIERRAONCOLOGY.COM
Registry Domain ID:
2069119634_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.networksolutions.com
Registrar URL:
http://networksolutions.com
Updated Date:
2018-08-27T08:58:43Z
Creation Date:
2016-10-26T16:51:42Z
Registry Expiry Date:
2019-10-26T16:51:42Z
Registrar: Network Solutions,
LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.8003337680
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS49.WORLDNIC.COM
Name Server: NS50.WORLDNIC.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2019-07-11T07:31:46Z

Similarly Ranked Websites


Test Page for the Nginx HTTP Server on Fedora

- butatech.com

1,862,978   $ 720.00

Моды для Euro Truck Simulator 2

- worldets2.ru

Моды к Euro Truck Simulator 2. Модификации, новые карты, отечественные и зарубежные грузовики, прицепы, грузы, легковые машины и прочее для симулятора ETS 2.

1,862,981   $ 720.00

سینما جم | دانلود | فیلم | سریال | مسابقه | انیمیشن

- cinemajem.ir

اگر به دنبال یک سایت مناسب برای دسترسی به آرشیو فیلم و سریال های ایرانی هستید، پیشنهاد می‌کنیم سایت سینما جم (Cinema Jem) را از دست ندهید.

1,863,001   $ 720.00

WOOD & Company | Homepage

- wood.cz

Wood is a leading Investment Bank focused on European Emerging markets. With over 150 employees spread across five regional offices and an international distribution hub in...

1,863,016   $ 720.00